An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold
- PMID: 29273417
- DOI: 10.1016/j.bmc.2017.10.012
An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold
Abstract
Pyrazolo[4,3-d]pyrimidine, a fused heterocycle bearing pyrazole and pyrimidine portions has gained a significant attention in the field of bioorganic and medicinal chemistry. Pyrazolo[4,3-d]pyrimidine derivatives have demonstrated numerous pharmacological activities particularly, anti-cancer, anti-infectious, phosphodiesterase inhibitors, adenosine antagonists and cytokinin antagonists etc. This review extensively unveils the synthetic and pharmacological diversity with special emphasis on structural variations around pyrazolo[4,3-d]pyrimidine scaffold. This endeavour has thus uncovered the medicinal worthiness of pyrazolo[4,3-d]pyrimidine framework. To the best of our knowledge this review is the first compilation on synthetic, medicinal and structure activity relationship (SAR) aspects of pyrazolo[4,3-d]pyrimidines since 1956.
Keywords: Anti-cancer agents; Anti-infectious agents; Cytokinin antagonists; PDE-5 inhibitors; Pyrazolo[4,3-d]pyrimidine; Synthetic strategies.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
New advances in synthesis and clinical aspects of pyrazolo[3,4-d]pyrimidine scaffolds.Bioorg Chem. 2018 Aug;78:341-357. doi: 10.1016/j.bioorg.2018.03.032. Epub 2018 Apr 3. Bioorg Chem. 2018. PMID: 29627655 Review.
-
Functional Pyrazolo[1,5-a]pyrimidines: Current Approaches in Synthetic Transformations and Uses As an Antitumor Scaffold.Molecules. 2021 May 5;26(9):2708. doi: 10.3390/molecules26092708. Molecules. 2021. PMID: 34063043 Free PMC article. Review.
-
An insight on synthetic and medicinal aspects of pyrazolo[1,5-a]pyrimidine scaffold.Eur J Med Chem. 2017 Jan 27;126:298-352. doi: 10.1016/j.ejmech.2016.11.019. Epub 2016 Nov 10. Eur J Med Chem. 2017. PMID: 27894044 Review.
-
Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.Eur J Med Chem. 2009 Nov;44(11):4385-92. doi: 10.1016/j.ejmech.2009.05.031. Epub 2009 Jun 12. Eur J Med Chem. 2009. PMID: 19586688
-
An overview on synthetic and pharmaceutical prospective of pyrido[2,3-d]pyrimidines scaffold.Chem Biol Drug Des. 2021 Mar;97(3):633-648. doi: 10.1111/cbdd.13800. Epub 2020 Sep 29. Chem Biol Drug Des. 2021. PMID: 32946161 Review.
Cited by
-
Pyrazolo - Pyrimidines as Targeted Anticancer Scaffolds - A Comprehensive Review.Med Chem. 2024;20(3):293-310. doi: 10.2174/0115734064251256231018104623. Med Chem. 2024. PMID: 37885114 Review.
-
Discovery of small molecule inhibitors of human uridine-cytidine kinase 2 by high-throughput screening.Bioorg Med Chem Lett. 2019 Sep 15;29(18):2559-2564. doi: 10.1016/j.bmcl.2019.08.010. Epub 2019 Aug 7. Bioorg Med Chem Lett. 2019. PMID: 31420268 Free PMC article.
-
Novel camphor-based pyrimidine derivatives induced cancer cell death through a ROS-mediated mitochondrial apoptosis pathway.RSC Adv. 2019 Sep 19;9(51):29711-29720. doi: 10.1039/c9ra05900h. eCollection 2019 Sep 18. RSC Adv. 2019. PMID: 35531556 Free PMC article.
-
Antibiofilm and Anti-Quorum-Sensing Activities of Novel Pyrazole and Pyrazolo[1,5-a]pyrimidine Derivatives as Carbonic Anhydrase I and II Inhibitors: Design, Synthesis, Radiosterilization, and Molecular Docking Studies.Antibiotics (Basel). 2023 Jan 9;12(1):128. doi: 10.3390/antibiotics12010128. Antibiotics (Basel). 2023. PMID: 36671329 Free PMC article.
-
Synthetic approaches for novel fused pyrimidine derivatives: Design, structural characterization, antiviral, antitumor, and molecular docking evaluation.Heliyon. 2024 Dec 4;10(24):e40903. doi: 10.1016/j.heliyon.2024.e40903. eCollection 2024 Dec 30. Heliyon. 2024. PMID: 39720060 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Miscellaneous